317 related articles for article (PubMed ID: 24684755)
1. Editorial: renal sympathetic denervation: a true lack of efficacy, or the victim of a "perfect storm"?
Baker NC; Waksman R
Cardiovasc Revasc Med; 2014 Mar; 15(2):61-2. PubMed ID: 24684755
[No Abstract] [Full Text] [Related]
2. Renal denervation in hypertension: simplicity, or complexity?
Lantelme P; Courand PY; Bricca G
Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
[No Abstract] [Full Text] [Related]
3. SYMPLICITY: not all that simple.
Luft FC
Kidney Int; 2014 May; 85(5):999-1001. PubMed ID: 24786869
[No Abstract] [Full Text] [Related]
4. Renal denervation: a plea for wisdom.
Lantelme P; Courand PY; Pathak A
Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
[No Abstract] [Full Text] [Related]
5. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
Kjeldsen SE; Os I; Mahfoud F
EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
[No Abstract] [Full Text] [Related]
6. Charting new frontiers in interventional medicine.
Fajadet J
EuroIntervention; 2013 May; 9 Suppl R():R10-1. PubMed ID: 23732138
[No Abstract] [Full Text] [Related]
7. The complexity after simplicity: how to proceed with renal denervation in hypertension?
Blankestijn PJ; Alings M; Voskuil M; Grobbee DE
Eur J Prev Cardiol; 2015 Apr; 22(4):412-4. PubMed ID: 24914028
[No Abstract] [Full Text] [Related]
8. Renal denervation for the treatment of hypertension: Making a new start, getting it right.
Weber MA; Kirtane A; Mauri L; Townsend RR; Kandzari DE; Leon MB
Catheter Cardiovasc Interv; 2015 Nov; 86(5):855-63. PubMed ID: 26097069
[TBL] [Abstract][Full Text] [Related]
9. Expanding the indication spectrum: renal denervation in diabetes.
Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
[TBL] [Abstract][Full Text] [Related]
10. Resistant Hypertension and Renal Nerve Denervation.
Denker MG; Cohen DL
Methodist Debakey Cardiovasc J; 2015; 11(4):240-4. PubMed ID: 27057294
[TBL] [Abstract][Full Text] [Related]
11. Current technologies: an introduction.
Daemen J
EuroIntervention; 2013 May; 9 Suppl R():R75-82. PubMed ID: 23732160
[No Abstract] [Full Text] [Related]
12. Challenging anatomy, how to treat or not to treat?
Zeller T; Rastan A; Macharzina R; Noory E
EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
[TBL] [Abstract][Full Text] [Related]
13. Follow-up, study design and outcome parameters.
Volpe M; Battistoni A; Tocci G
EuroIntervention; 2013 May; 9 Suppl R():R96-100. PubMed ID: 23732163
[TBL] [Abstract][Full Text] [Related]
14. Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?
Laffin LJ; Bakris GL
Am J Hypertens; 2017 Sep; 30(9):841-846. PubMed ID: 27838622
[TBL] [Abstract][Full Text] [Related]
15. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension.
Gewirtz JR; Bisognano JD
Cardiol J; 2011; 18(1):97-102. PubMed ID: 21305496
[No Abstract] [Full Text] [Related]
16. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
Bunte MC; Infante de Oliveira E; Shishehbor MH
JACC Cardiovasc Interv; 2013 Jan; 6(1):1-9. PubMed ID: 23266234
[TBL] [Abstract][Full Text] [Related]
17. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
[TBL] [Abstract][Full Text] [Related]
18. Early reduction of therapy-resistant hypertension in a patient after single-sided renal denervation approach.
Schroeter MR; Koziolek M
Clin Res Cardiol; 2014 Jan; 103(1):79-81. PubMed ID: 24249314
[No Abstract] [Full Text] [Related]
19. Now That Renal Denervation Works, How Do We Proceed?
Papademetriou V; Stavropoulos K; Doumas M; Tsioufis K
Circ Res; 2019 Mar; 124(5):693-695. PubMed ID: 30817252
[No Abstract] [Full Text] [Related]
20. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
Epstein M; de Marchena E
J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
